Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3065 |
|
Actual shortage: | 232 (8%) | |
Anticipated shortage: | 15 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2809 (92%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
30 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-MIRTAZAPINE | 30MG | TABLET | Resolved | 2019-01-09 | 2019-02-01 | 71676 |
APO-FAMCICLOVIR | 500MG | TABLET | Resolved | 2019-01-15 | 2019-04-26 | 72354 |
APO-RISEDRONATE | 150MG | TABLET | Resolved | 2019-01-15 | 2019-03-11 | 72360 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2019-01-23 | 2019-03-07 | 73308 |
APO-DOMPERIDONE | 10MG | TABLET | Resolved | 2019-01-23 | 2019-08-26 | 73311 |
APO-ALLOPURINOL | 300MG | TABLET | Resolved | 2019-01-30 | 2019-02-13 | 74014 |
MIRVALA 28 | 0.1500MG 0.0300MG | TABLET | Resolved | 2019-01-30 | 2019-04-26 | 74028 |
APO-ERLOTINIB | 100MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74875 |
APO-ERLOTINIB | 150MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74878 |
APO-ERLOTINIB | 25MG | TABLET | Resolved | 2019-02-06 | 2019-11-21 | 74881 |
APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2019-02-06 | 2019-02-25 | 74894 |
APO-LEVOCARB-TAB 25MG/100MG | 25MG 100MG | TABLET | Resolved | 2019-02-06 | 2019-02-25 | 74896 |
APO-LEVOCARB - TAB 25MG/250MG | 25MG 250MG | TABLET | Resolved | 2019-02-06 | 2019-03-01 | 74911 |
APO-OLANZAPINE | 2.5MG | TABLET | Resolved | 2019-02-06 | 2019-03-29 | 74914 |
APO-OLANZAPINE | 20.0MG | TABLET | Resolved | 2019-02-06 | 2019-03-29 | 74917 |
APO-OLANZAPINE | 5.0MG | TABLET | Resolved | 2019-02-06 | 2019-03-29 | 74922 |
APO-VARENICLINE | 1MG | TABLET | Resolved | 2019-02-06 | 2019-06-24 | 74935 |
APO-AMLODIPINE-ATORVASTATIN | 10MG 80MG | TABLET | Resolved | 2019-02-13 | 2019-04-22 | 75608 |
APO-LEVOFLOXACIN | 250MG | TABLET | Resolved | 2019-02-13 | 2019-03-07 | 75620 |
APO-OLANZAPINE | 7.5MG | TABLET | Resolved | 2019-02-13 | 2019-03-30 | 75623 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-NAPRO-NA | 275MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60657 |
APO-NAPRO-NA DS | 550MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60660 |
APO NAPROXEN TAB 125MG | 125MG | TABLET | Discontinued | 2018-09-08 | 2019-08-08 | 60663 |
APO-NAPROXEN | 250MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60666 |
APO-OLANZAPINE | 10.0MG | TABLET | Discontinued | 2018-09-08 | 2018-12-18 | 60672 |
APO-OXAZEPAM | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-08-30 | 60675 |
APO-OXAZEPAM | 15MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60678 |
APO-OXAZEPAM | 30MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60681 |
APO-PAROXETINE | 20MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60684 |
APO PREDNISONE TAB 5MG | 5MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60699 |
APO-QUETIAPINE | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60708 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60723 |
APO-RANITIDINE TABLET 150MG | 150MG | TABLET | Discontinued | 2018-09-08 | 2018-12-28 | 60726 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60729 |
APO-RANITIDINE TABLET 300MG | 300MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60732 |
APO-RILUZOLE | 50MG | TABLET | To be discontinued | 2018-09-08 | 2018-09-08 | 60744 |
APO-RISEDRONATE | 35MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60747 |
APO-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60750 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-07-13 | 60758 |
APO-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2018-09-08 | 2019-02-13 | 60763 |